NLM Gateway
A service of the U.S. National Institutes of Health
Your Entrance to
Resources from the
National Library of Medicine
    Home      Term Finder      Limits/Settings      Search Details      History      My Locker        About      Help      FAQ    
Skip Navigation Side Barintended for web crawlers only

Decreasing levels of anti-Nef antibody correlate with increasing viral loads in HIV-1 infected people with differing clinical status.

Chen YM, Lin RH, Fu CY, Lin RY, Syu WJ; International Conference on AIDS.

Int Conf AIDS. 1998; 12: 810 (abstract no. 42186).

Institute of Public Health, National Yang-Ming University, Taipei, Taiwan, ROC.

OBJECTIVES: To study the correlations between antibody reactivities to HIV-1 Gag (p17-p24)/Nef/Tat/IN and viral loads in patients with differing clinical status (T4 cell counts). DESIGN: Cross-sectional study. METHODS: 174 patients which including 34 healthy carriers, 94 with AIDS related complex and 46 AIDS patients were enrolled and their HIV-1 viral loads were tested using branched-DNA signal amplification assay. The patients were divided into 4 quartiles according to their viral loads. 3 plasmids-pGEX-Tat, pGEX-Gag and pHis-IN were constructed and 4 recombinant proteins were induced and purified for Western blot assays. Densitometer scanning was used to determine the level of antibody reactivity. RESULTS: A negative linear correlation was noted between the patients' viral loads and CD4+ T-cell counts (Spearman's r = -0.41, P < 0.0001). The seropositive rates of anti-Gag, anti-Nef, anti-Tat and anti-IN antibodies of the patients were 81.0%, 77.1%, 50.3% and 93.3%, respectively. There were significant differences of the rates of anti-Gag antibody among 4 groups of patients with different levels of viral loads. Besides the anti-Gag antibody, the magnitude of anti-Nef antibody reactivity showed significant association with different levels of CD4+ T-cell counts (Mantel-Haenszel chi 2 test, P = 0.012; gamma = -0.233) and viral loads (P = 0.002, gamma = -0.252). However, McNemar's test showed that there was no significant association between the anti-Gag and anti-Nef antibodies in the assay mentioned above. CONCLUSION: The anti-Gag (p17-p24) and anti-Nef antibody reactivities were significantly but independently associated with different levels of patients' viral loads and CD4+ T-cell counts. Neither anti-Tat nor anti-IN antibodies were useful as a clinical marker for AIDS disease progression.

Publication Types:
  • Meeting Abstracts
Keywords:
  • AIDS-Related Complex
  • Acquired Immunodeficiency Syndrome
  • Blotting, Western
  • CD4 Lymphocyte Count
  • CD4-Positive T-Lymphocytes
  • Cross-Sectional Studies
  • Disease Progression
  • Gene Products, tat
  • Genes, gag
  • Genes, tat
  • HIV-1
  • Humans
  • Viral Load
  • genetics
  • organization & administration
Other ID:
  • 98403116
UI: 102230985

From Meeting Abstracts




Contact Us
U.S. National Library of Medicine |  National Institutes of Health |  Health & Human Services
Privacy |  Copyright |  Accessibility |  Freedom of Information Act |  USA.gov